Product logins

Find logins to all Clarivate products below.


Laparoscopic Devices | Market Insights | Europe | 2022

Procedure deferrals due to the COVID-19 pandemic severely impacted the European laparoscopic device market in 2020, and the elective nature of many postponed procedures will hinder the pace of recovery to some extent. However, as the situation improves, the European laparoscopic device market will grow modestly through the forecast period, driven by continuing growth in laparoscopic procedures, increasing device penetration into procedures, and the adoption of premium-priced products, particularly in the direct energy device and endolinear stapler and cutter markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for laparoscopic devices in Europe across an 11-year period.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period because of rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and increased…